San Diego, CA, United States of America

Cheryl (Billstrom) Sifferlen


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Cheryl (Billstrom) Sifferlen

Introduction

Cheryl (Billstrom) Sifferlen is a notable inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on Salinosporamide A. Her dedication to research and development has led to the creation of valuable formulations that have the potential to impact patient care.

Latest Patents

Cheryl Sifferlen holds a patent for "Lyophilized formulations of Salinosporamide A." This patent includes lyophilized formulations comprising Salinosporamide A or its analogs, along with bulking agents. The patent also outlines methods for lyophilizing Salinosporamide A and its analogs, utilizing a solvent or co-solvent system. Furthermore, it provides methods for administering Salinosporamide A to patients, showcasing her commitment to advancing medical treatments.

Career Highlights

Cheryl has been associated with Nereus Pharmaceuticals, Inc., where she has played a crucial role in the development of innovative pharmaceutical solutions. Her work has not only contributed to the company's success but has also positioned her as a key figure in the pharmaceutical industry.

Collaborations

Cheryl has collaborated with esteemed colleagues, including Barbara Christine Potts and Ramsharan Singh. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Cheryl (Billstrom) Sifferlen's contributions to the field of pharmaceuticals through her patent on Salinosporamide A exemplify her innovative spirit and dedication to improving patient outcomes. Her work continues to inspire future advancements in medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…